Boost your inner glow and optimize your output with these IV drips to prep you pre-summer and post-summer shine.

Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in ...

US pharma giant Merck & Co (NYSE: MRK) today announced positive top-line results from the pivotal Phase III MK-3475A-D77 ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

Merck’s anti-PD-1 therapy, available for intravenous use as KEYTRUDA ®, together with berahyaluronidase alfa, a hyaluronidase variant developed and manufactured by Alteogen Inc. (MK-3475A; ...

The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025 Phase III Clinical ...

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.

New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge ...

It's approved by the Food and Drug Administration (FDA) to manage anxiety symptoms, treat alcohol withdrawal symptoms, and as add-on therapy for skeletal muscle spasms and convulsive disorders.

Here are the morning's top stories on Tuesday, November 19, 2024… If you’re one of the unlucky people who get bitten by a ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

A blocked bile duct in cats can make them very ill. These are the causes, symptoms, diagnosis, and treatments of a blocked ...